Good Distribution Practice and the Indian pharmaceutical exporter: a one-day audit checklist.

GDP is the quieter half of the pharmaceutical quality system. GMP ends when the batch is released at the manufacturer's warehouse. From that point to the dispense window, the discipline is Good Distribution Practice, and the failure modes are not clean-room contamination but tarmac dwell, logger gaps and generator cut-over. An Indian exporter's GDP credibility sits in the documents the destination QA reviewer opens on the day the container arrives.

What GDP is, and where it picks up from GMP.

Good Distribution Practice (GDP) is the quality system that governs pharmaceutical handling from the moment the batch is released at the manufacturer's warehouse to the moment the dispensed pack reaches a patient-facing pharmacy. It is the bridge between GMP at the factory gate and the pharmacy shelf at the hospital end.

GDP covers nine operational areas:

• Quality management system — documented, version-controlled, maintained.
• Qualified personnel with training records, especially for cold-chain handling.
• Premises — temperature, humidity, pest control, security, zoning.
• Equipment — qualified and calibrated, with traceability to national standards.
• Operations — receipt, storage, picking, packing, dispatch, returns, recalls.
• Documentation — storage records, transport records, temperature logs.
• Complaints, recalls and falsified medicines process.
• Transportation — temperature control, security, qualified vehicles.
• Sub-contracts — every sub-contractor must also meet GDP.

GDP is deceptively simple on the page and relentlessly operational in practice. A supplier either lives inside the system or does not — the paperwork exposes which one within an hour of opening the binder.

The four standards in play: EU, MHRA, WHO, USP.

The GDP conversation is governed by four overlapping texts, depending on where the medicine is going.

EU GDP — 2013/C 343/01

The Commission Guidelines on Good Distribution Practice of medicinal products for human use, 2013/C 343/01, updated November 2013, applies in all EEA member states. It is the de facto global reference for cross-border pharmaceutical distribution. The text is nine chapters long and forms the benchmark most QA reviewers read from, even when the destination market is not in the EU.

MHRA GDP — UK post-Brexit

Post-Brexit, the UK's Medicines and Healthcare products Regulatory Agency runs its own parallel GDP regime, administered under the Human Medicines Regulations 2012 (as amended). The text closely mirrors EU GDP, but the MHRA inspectorate is a separate authority and holds its own Wholesale Dealer's Authorisation (WDA(H)) licences. For UK imports, the MHRA reference is the one that governs the importer of record.

WHO TRS 957 Annex 5

The World Health Organisation's Technical Report Series 957, Annex 5 — Good Storage and Distribution Practices for Pharmaceutical Products, is the text most widely cited in the WHO pre-qualification programme and in African regulatory frameworks. It is the working reference for exports into Nigeria, Kenya, Ghana, Ethiopia and most other African markets.

USP General Chapters <1079> and <659>

For shipments into North America, or into markets that cross-reference US Pharmacopeia standards, USP <1079> (Good Storage and Distribution Practices for Drug Products) and USP <659> (Packaging and Storage Requirements) are the relevant texts. They align closely with the WHO and EU references but use different language around excursion management.

The Indian regulatory reality.

Here is the honest picture that every destination QA reviewer should understand.

India does not have a single harmonised "Indian GDP" standard enforced nationally in the way EU GDP is enforced across the EEA. The functional Indian regulatory surface is Schedule M-III and Schedule Y of the Drugs and Cosmetics Rules, both of which have limited coverage of the distribution layer. WHO TRS 957 Annex 5 is the most commonly adopted voluntary or contractual reference.

What actually exists in practice:

• Indian WHO-GMP manufacturers typically hold their own in-house GDP SOPs, modelled on EU GDP or WHO TRS 957. These are audited by the manufacturer's QA team and by destination-market importers.
• Indian 3PL cold-chain providers — Snowman Logistics, ColdEx, Gati Kausar and similar operators — hold their own GDP-aligned qualifications and warehouse certifications.
• The calibration chain is served by NABL — the National Accreditation Board for Testing and Calibration Laboratories — which is an ILAC MRA signatory. NABL-traceable calibration certificates are accepted by EU, MHRA and WHO inspectors on their own merit.

So the practical question for a destination QA reviewer is not "does the Indian exporter hold an EU GDP licence?" — no exporter does, because GDP licences are held by the importer on the destination side. The real question is whether the chain-of-custody documentation the Indian supplier produces — temperature logs, validated container qualification, driver training records, calibration certificates — meets the evidentiary standard of the GDP regime that governs the importer of record.

When the importer's inspectorate turns up, they read the Indian supplier's documents. That is where the audit lives.

The ten-item audit pack.

Ten documents, in the order a QA reviewer should ask for them. A supplier that produces all ten in a working morning has a real GDP system. A supplier that needs a week to assemble them does not.

1. Warehouse temperature mapping. Minimum 10-15 days of mapping data per season. The thermal profile must cover peak summer and peak monsoon, with mapping sensors placed against a documented grid. A map from three years ago in one season only is a red flag.
2. Container qualification. Validated shipper qualification for the units in use. Active shippers — Envirotainer, CSafe, VaxiCool. Passive shippers — va-Q-tec, Softbox, Peli BioThermal. Each configuration needs named summer and winter profiles.
3. Transport qualification — lane by lane. Lane-qualification studies for the specific route. For a Mumbai-to-Dubai consignment: the Mumbai warehouse move to BOM airport, the BOM handling dwell, the BOM-DXB flight leg, the DXB cool-dolly transfer, the DXB importer warehouse receipt. Not "generic" qualification — the specific lane.
4. Temperature loggers. Calibrated loggers with NABL-traceable calibration certificates, programmed for the lane's time-temperature envelope. Five-minute polling on a six-hour leg, or six-hour polling on a forty-minute leg, is a programming-discipline red flag.
5. Excursion protocol. A written protocol defining criteria for investigating, quarantining and releasing excursion product. Stability-data-justified excursion windows. An excursion log from the last 12 months showing real decisions, not a blank template.
6. Driver and handler training records. Training records covering cold-chain handling, break-of-cold-chain protocols and emergency response. Records should name individuals and show training dates within the last 12 months.
7. Calibration chain. All measurement instruments — warehouse temperature sensors, loggers, reference thermometers — traceable to NABL-accredited calibration laboratories. Certificates should be in date and the traceability chain should be visible end-to-end.
8. Recall capability. A mock-recall exercise record within the last 12 months is the strongest signal. It shows the supplier can reach every unit in the distribution chain inside the time window the regulator expects.
9. Distribution partner audit file. The Indian manufacturer should audit its 3PL logistics partner at least annually and hold the audit file on request. No audit file means no oversight.
10. Temperature logs for the last 12 months. Available in minutes if the QA system is real. Hours of searching is a sign that logs live on individual computers rather than in a controlled document system.

Seven things that typically break the chain.

Over enough shipments into the GCC, Africa and the EEA, the failure modes converge. These seven account for the overwhelming majority of excursions, rejections and QA-review stalls.

1. Tarmac dwell at Lagos, Mombasa, Addis or BOM pre-monsoon. No passive shipper tolerates a 45°C 6-hour wait. An active shipper has limits too. Tarmac dwell is the single biggest eater of thermal holdover.
2. Generator failure at origin warehouse during monsoon power-cuts. Mitigation is a UPS bridge plus diesel backup with automatic cut-over, tested quarterly. A supplier that cannot produce the quarterly cut-over test record is running on hope.
3. Customs clearance delays at destination pushing outside the validated lane envelope. A lane qualified for 72 hours is not qualified for 96. Clearance delays eat safety buffer that was sized for transit variance, not inspection queues.
4. Handler error at transfer points. A pallet left in the sun on a break-bulk transfer. A ULD broken down in the wrong order. These are training-record failures in disguise.
5. Logger programming wrong for the actual lane. Five-minute polling frequency on a lane with 6-hour transit leaves gaps. Six-hour polling frequency on a 40-minute leg produces three data points. Both are red flags in audit.
6. Missing documentation at dispatch. Container qualification certificate expired. Driver training record missing for the dispatch window. The container goes, the paperwork does not, and the importer's inspectorate holds the consignment on arrival.
7. Generic instead of lane-specific qualification. The supplier has a qualification — but not for the specific lane you are importing on. Mumbai-to-Dubai is not Mumbai-to-Lagos. A qualification for the first does not cover the second. This is the most common audit finding on suppliers that have grown into new corridors without requalifying.

For a cold-chain-specific treatment of the same failure modes on the West African corridor, see the 72-hour cold chain to Lagos.

Running a one-day GDP audit on an Indian exporter.

A working GDP audit of an Indian supplier takes one full working day on site, or two half-days remote with document pre-share and a live warehouse walk-through by video. Here is the shape the day should take.

Morning — the document pack

Ask for the ten-item audit pack at 09:00. The supplier should produce eight of the ten within the morning. Items 1, 2, 3 and 7 (mapping, container qualification, lane qualification, calibration) sit in the QA file. Items 4, 5, 6 and 10 (loggers, excursion protocol, training records, 12-month temperature logs) sit in the operational system. Items 8 and 9 (mock recall, 3PL audit) sit in the compliance register.

Midday — the warehouse walk

Walk the warehouse with a reference thermometer. Check mapping-sensor placement against the documented grid. Open one cold room. Check logger placement. Ask to see the cut-over test on the backup generator. Watch a dispatch. A supplier that lives inside a real system looks the same at 13:00 on an audit day as at 13:00 on any other Tuesday.

Afternoon — the deep cuts

Pull a random excursion from the log and walk the investigation, the stability-data reference and the release decision. Pull a random shipment from last month and ask for the complete chain-of-custody document set. Ask to see the last recall exercise. Ask for the NABL calibration certificate for the reference thermometer in the QA lab.

What's a red flag

Documents that are "being updated" — they should already be current. A mapping study older than 18 months with no interim verification. Any instrument without a visible calibration sticker. A logger data point gap without a written investigation. A 3PL contract with no GDP clause. An excursion log with no releases or destructions in 12 months — either the lane is perfect, which is improbable, or the log is not being maintained.

A well-run Indian exporter should pass a one-day GDP audit with minor observations, not major findings. If the audit produces major findings, the findings tend to cluster around documentation age and lane-specificity rather than operational capability.

FAQ

Does an Indian pharmaceutical exporter need to hold an EU GDP or MHRA GDP licence?

No. EU GDP and MHRA GDP licences — specifically the Wholesale Dealer's Authorisation, WDA(H) in the UK, and the equivalent EU member-state licences — are held by the importer of record on the destination side. An Indian exporter cannot hold one. What the Indian exporter must do is produce chain-of-custody documentation that meets the evidentiary standard of the destination GDP regime. The importer's inspectorate reads the Indian supplier's documents during any routine or for-cause audit of the importer.

What is the difference between WHO TRS 957 Annex 5 and EU GDP 2013/C 343/01?

WHO TRS 957 Annex 5 (Good Storage and Distribution Practices for Pharmaceutical Products) is the World Health Organisation's reference text, widely cited in African markets and in the WHO pre-qualification programme. EU GDP 2013/C 343/01 is the European Commission's legally binding guidance for EEA member states. The two texts overlap substantially on quality-system requirements, personnel, premises, equipment, operations and documentation. EU GDP is more prescriptive on qualified-person oversight and on the wholesale-dealer licence framework; WHO TRS 957 is more operational and is written for broader international application.

What does NABL traceability mean and why does it matter for GDP?

The National Accreditation Board for Testing and Calibration Laboratories is India's accreditation body for calibration and testing laboratories. NABL is a signatory to the International Laboratory Accreditation Cooperation Mutual Recognition Arrangement (ILAC MRA), which means NABL-accredited calibration certificates are recognised by EU, MHRA, WHO and USP-aligned inspectorates on their own merit. For GDP, this matters because every temperature sensor, logger and reference thermometer in the chain must have calibration traceable to a national standard. NABL-traceable certificates close that loop without additional paperwork at the destination end.

Can M Care share its GDP documentation pack for a specific corridor?

Yes. We run a documented GDP programme aligned to EU GDP 2013/C 343/01 and WHO TRS 957 Annex 5 across our dispatch operations from Mumbai. Warehouse mapping, container qualification, lane qualification for each active corridor, NABL-traceable calibration records, driver and handler training files and the full excursion log are maintained and shareable with QA reviewers. Tell us the destination corridor — London Heathrow, Dubai, Riyadh, Lagos, Nairobi, Accra — and we will share the lane qualification pack for that corridor, with the document dates visible on the front page.